Welcome to CDC stacks | HPV type attribution in high grade cervical lesions in the United States - 62208 | Advisory Committee on Immunization Practices (ACIP)
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
HPV type attribution in high grade cervical lesions in the United States
Filetype[PDF-577.44 KB]


  • Supporting Files:
    No Additional Files
    1. Summary and future ACIP HPV Vaccine Workgroup plans
      Personal Author:
      Markowitz, Lauri E.
      Corporate Author:
      National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. Division of STD Prevention.
      Conference Author:
      United States. Advisory Committee on Immunization Practices. Meeting (2014 February 26-27 : Atlanta, GA)
      Published:
      February 27, 2014
      Source:
      06-Flu-Cano.pdf
      Series:
      ACIP meeting Human Papillomavirus (HPV) Vaccines Update
      File Type:
      Filetype[PDF - 277.03 KB]
    2. 9-valent HPV (9vHPV) vaccine program key results
      Personal Author:
      Luxembourg, Alain
      Corporate Author:
      Merck Research Laboratories.
      Conference Author:
      United States. Advisory Committee on Immunization Practices. Meeting (2014 February 26-27 : Atlanta, GA)
      Published:
      February 27, 2014
      Source:
      05-HPV-Markowitz.pdf
      Series:
      ACIP meeting Human Papillomavirus (HPV) Vaccines Update
      File Type:
      Filetype[PDF - 255.99 KB]
    3. Population-based HPV genotype attribution in HPV-associated cancers, United States
      Personal Author:
      Saraiya, Mona
      Corporate Author:
      National Center for Chronic Disease Prevention and Health Promotion (U.S.). Division of Cancer Prevention and Control.
      Conference Author:
      United States. Advisory Committee on Immunization Practices. Meeting (2014 February 26-27 : Atlanta, GA)
      Published:
      February 27, 2014
      Source:
      05-Flu-Grohskopf.pdf
      Series:
      ACIP meeting Human Papillomavirus (HPV) Vaccines Update
      File Type:
      Filetype[PDF - 1006.96 KB]
    4. Human papillomavirus (HPV) vaccine session
      Personal Author:
      Bocchini, Joseph A.
      Corporate Author:
      United States. Advisory Committee on Immunization Practices. HPV Vaccines Work Group
      Conference Author:
      United States. Advisory Committee on Immunization Practices. Meeting (2014 February 26-27 : Atlanta, GA)
      Published:
      February 27, 2014
      Source:
      04-Mening-Patel.pdf
      Series:
      ACIP meeting Human Papillomavirus (HPV) Vaccines Update
      File Type:
      Filetype[PDF - 188.38 KB]
You May Also Like:
  1. Advisory Committee on Immunization Practices (ACIP) summary report : February 26-27, 2014, Atlanta, Georgia
    Corporate Author:
    United States. Advisory Committee on Immunization Practices.
    Conference Author:
    United States. Advisory Committee on Immunization Practices. Meeting (2014 February 26-27 : Atlanta, GA)
    Published:
    2010
    Series:
    ACIP meeting Minutes
    Description:
    February 26-27 2014 ACIP Meeting Minutes
    File Type:
    Filetype[PDF - 1.69 MB]
  2. 9-valent HPV vaccine (9vHPV) GRADE policy questions, available data, PICO
    Personal Author:
    Dunne, Eileen F.
    Conference Author:
    United States. Advisory Committee on Immunization Practices. Meeting (2014 June 25-26 : Atlanta, GA)
    Published:
    June 25, 2014
    Series:
    ACIP meeting Human Papillomavirus (HPV) Vaccines Update
    File Type:
    Filetype[PDF - 224.97 KB]
  3. Effect of Highly Active Antiretroviral Therapy (HAART) and Menopause on Risk of Progression of Cervical Dysplasia in Human Immune-Deficiency Virus- (HIV-) Infected Women
    Personal Author:
    Kim, Suk Chul; Messing, Susan; Shah, Krupa; Luque, Amneris E.;
    Published:
    Dec 18 2013
    Source:
    Infect Dis Obstet Gynecol. 2013; 2013.
    Description:
    More HIV-infected women are reaching older age and menopause, but there is limited information on cervical squamous intraepithelial lesions (SILs) on these women.|To assess the effect of HAART and menopause on SILs in HIV-infected women, we reviewed ...
    File Type:
    Filetype[PDF - 601.91 KB]
  4. Summary and future ACIP HPV Vaccine Workgroup plans
    Personal Author:
    Markowitz, Lauri E.
    Corporate Author:
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. Division of STD Prevention.
    Conference Author:
    United States. Advisory Committee on Immunization Practices. Meeting (2014 February 26-27 : Atlanta, GA)
    Published:
    February 27, 2014
    Source:
    06-Flu-Cano.pdf
    Series:
    ACIP meeting Human Papillomavirus (HPV) Vaccines Update
    File Type:
    Filetype[PDF - 277.03 KB]
  5. Use of 9-Valent Human Papillomavirus (HPV) Vaccine: Updated HPV Vaccination Recommendations of the Advisory Committee on Immunization Practices
    Personal Author:
    Petrosky, Emiko; Bocchini, Joseph A.; Hariri, Susan; Chesson, Harrell; Curtis, C. Robinette; Saraiya, Mona; Unger, Elizabeth R.; Markowitz, Lauri E.;
    Corporate Author:
    United States. Advisory Committee on Immunization Practices.
    Published:
    Mar 27 2015
    Source:
    MMWR Morb Mortal Wkly Rep. 2015; 64(11):300-304.
    Description:
    During its February 2015 meeting, the Advisory Committee on Immunization Practices (ACIP) recommended 9-valent human papillomavirus (HPV) vaccine (9vHPV) (Gardasil 9, Merck and Co., Inc.) as one of three HPV vaccines that can be used for routine vacc...
    File Type:
    Filetype[PDF - 211.71 KB]